Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-15,000
Closed -$163K 256
2025
Q2
$163K Hold
15,000
0.05% 222
2025
Q1
$187K Hold
15,000
0.06% 209
2024
Q4
$123K Hold
15,000
0.04% 223
2024
Q3
$123K Hold
15,000
0.04% 224
2024
Q2
$102K Buy
15,000
+5,000
+50% +$34.2K 0.03% 219
2024
Q1
$50.1K Buy
10,000
+1,500
+18% +$3.19K 0.02% 226
2023
Q4
$18.7K Hold
8,500
0.01% 213
2023
Q3
$20.9K Hold
8,500
0.01% 198
2023
Q2
$66.5K Buy
8,500
+1,000
+13% +$7.15K 0.03% 209
2023
Q1
$49.4K Hold
7,500
0.03% 215
2022
Q4
$43.6K Buy
+7,500
New +$46.9K 0.03% 194

Other funds holding MESO

Chapin Davis's MESO Position: Q3 2025 in Review

Chapin Davis sold out of Mesoblast (MESO) in Q3 2025, closing a stake of 15,000 shares — an estimated $163K sold.

Chapin Davis first reported a position in MESO in Q4 2022 and held it in 11 quarters. The position peaked at $187K in Q1 2025. 68 funds tracked by Wall St. Rank hold MESO as of Q3 2025.

  • Chapin Davis reported no remaining Mesoblast position as of Q3 2025 after selling out during the quarter.
  • Chapin Davis sold 15,000 Mesoblast shares in Q3 2025, an estimated $163K.
  • Chapin Davis first reported a position in Mesoblast in Q4 2022 and held it in 11 quarters.
  • Chapin Davis's Mesoblast position peaked at $187K in Q1 2025.
  • 68 funds tracked by Wall St. Rank held Mesoblast as of Q3 2025.

Based on Chapin Davis's 13F filing for Q3 2025, filed 9 Oct 2025.